60
Participants
Start Date
July 5, 2017
Primary Completion Date
March 7, 2022
Study Completion Date
March 7, 2022
Bupivacaine Hydrochloride
For active drug, 0.25% marcaine, will be used.
Placebo Drug
For sham drug, 0.9% saline, will be used.
Pulsed Electromagnetic Field (PEMF) Device
The pulsed electromagnetic field signal will consist of a 2-m sec burst of 27.12 megahertz (MHz) radiofrequency sinusoidal waves repeating at 2 bursts/second.
Placebo Device
Sham devices will appear identical to and will be used in exactly the same manner as active devices but will produce no electromagnetic field.
Ropivacaine Hydrochloride
For active drug, 0.25% naropin, will be used.
Columbia University Irving Medical Center, New York
Columbia University
OTHER